StockWatch
·
Pharmaceuticals
Dividend30 Sept 2026, 06:20 pm

Gujarat Themis Biosyn Approves Dividend & Fund Raising

AI Summary

Gujarat Themis Biosyn Ltd announced key resolutions passed by its members, including the approval of a dividend of ₹0.67 per equity share (67%) for the Financial Year ended March 31, 2026, amounting to ₹8,72,01,642. The company also received approval for raising funds through a preferential issue and amendments to its Articles of Association. The AOA amendment specifically allows financial institutions to appoint observers on the Board under certain conditions related to outstanding liabilities or debentures.

Key Highlights

  • Approved dividend of ₹0.67 per share for FY26.
  • Members approved raising funds via preferential issue.
  • Articles of Association amended to grant board observer rights to financial institutions.
  • Total dividend payout amounts to ₹8,72,01,642.